111 – 120 of 148
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
From gamma-carboxy-glutamate to protein C.
(
- Contribution to journal › Article
-
Mark
Are randomized clinical trials the only truth? Not always
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
(
- Contribution to journal › Scientific review
-
Mark
The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
(
- Contribution to journal › Article
-
Mark
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)
(
- Contribution to journal › Article
-
Mark
Family secrets to be disclosed.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes
(
- Contribution to journal › Letter
- 2005
-
Mark
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination - a rebuttal
(
- Contribution to journal › Letter
-
Mark
Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma.
(
- Contribution to journal › Article
-
Mark
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
(
- Contribution to journal › Article